The largest database of trusted experimental protocols

Pcdh cmv mcs ef1 puro

Manufactured by System Biosciences
Sourced in United States, China, Canada

The PCDH-CMV-MCS-EF1-Puro is a plasmid vector designed for the expression of genes of interest in mammalian cells. It features a cytomegalovirus (CMV) promoter for high-level expression, a multiple cloning site (MCS) for insertion of the gene of interest, and a puromycin resistance gene for selection of transfected cells.

Automatically generated - may contain errors

84 protocols using pcdh cmv mcs ef1 puro

1

Molecular Cloning of HBV and AMPK Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wild type (WT) and HBx-deficient mutant constructs of replication-competent 1.3 mer HBV subtype ayw were kindly provided by Dr. Wang-Shick Ryu (Yonsei Univ, South Korea). pCDH-hNTCP-C9 generated from the human NTCP-C9 (hNTCP-C9) construct in pcDNA6.1, kindly provided by W. Li [30 (link)], has been described [31 (link)]. The codon optimized CaMKII α gene was synthesized and inserted into an EcoR I-linearized pBHA plasmid, resulting in the plasmid pBHA-CaMKII α. To generate pCMV10-HA-CaMKII α, PCR-amplified CaMKII α DNA (Table S1) from pBHA-CaMKII α was subcloned into the EcoR I-linearized vector pCMV10-HA. To generate pCMV10-Myc-AMPK α1, PCR-amplified AMPK α1 DNA from pHA-AMPK α1 (provided by Dr. Joohun Ha) [32 (link)] (Table S1) was subcloned into the Msc I- and EcoR I-linearized vector pCMV10-Myc. A lentiviral expression vector encoding the HA-CaMKII α gene was generated by inserting Xba I- and BamH I-digested HA-CaMKII α DNA into the linearized pCDH-CMV-MCS-EF1-Puro (System Biosciences; CD510B-1) vector, and a lentiviral encoding the Myc-AMPK α1 gene was generated by inserting Xba I- and EcoR I-digested Myc-AMPK α1 DNA into linearized pCDH-CMV-MCS-EF1-Puro. The luciferase reporter pGL3-EnhII/Cp, pGL3-EnhI/Xp, pGL3-preS1p, and pGL3-preS2p constructs have been described previously [33 (link)].
+ Open protocol
+ Expand
2

Plasmid Constructs for TDP2 Mutant Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
pGEX-2TK-EAPII (TDP2) was provided by Dr. Runzhao Li at Emory University and was described previously [2 (link)]. pGEX-2TK-TDP2S60A harbouring a point mutation of serine 60 to alanine and pGEX-2TK-TDP2S60D harbouring a point mutation of serine 60 to aspartic acid were generated by site-directed mutagenesis using the Quick-change kit (Stratagene, La Jolla, CA) and the sequence of the resulting mutant was verified by sequencing. pCMV-HA-TDP2 was provided by Drs. Rui Gao and Yves Pommier at NCI and was described previously [5 (link)]. pGIPZ lentiviral shRNAmir expression constructs, including non-silencing negative control pGIPZ-shCtrl (RHS4346), pGIPZ-shERK3 (clone ID V3LHS_344615) and pGIPZ-shTDP2 (clone ID V2LHS_234163), were purchased from Open Biosystems. pCDH-TDP2 was generated by inserting the TDP2 fragment released from pGEX-2TK-TDP2 by Dra I/Stu I digestion into pCDH-CMV-MCS-EF1-Puro (System Biosciences) digested with Swa I. Similarly, pCDH-TDP2S60A and pCDH-TDP2S60D were generated by inserting TDP2S60A and TDP2S60D, respectively, into pCDH-CMV-MCS-EF1-Puro.
+ Open protocol
+ Expand
3

Reagents and Plasmids for Cell Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Actinomycin D (A1410), Tunicamycin (T7765), cycloheximide (01810), MG132 (C221), Leupeptin (L9783), NH4Cl (254134), Choroquine (C6628) and Bafilomycin A1 (B1793) were purchased from Sigma. Brefeldin A (9972) was purchased from Cell signaling. Egfr siRNA was purchased from Santa Cruz Biotechnology Inc. siGENOME Gprc5a siRNAs was purchased from Dharmacon. TRC Lentiviral EGFR shRNA was purchased from Dharmacon. The sequences were shown in Supplementary Data 4. The target DNA fragments for plasmid construction were amplified using PCR with human and mouse cDNA library as a template, which were inserted into the suitable clone sites of vectors. All primers for construction were list in Supplementary Data 4. Vector plasmids: pCDH-CMV-MCS-EF1-Puro from System Biosciences; p3XFLAG-CMV-10 from sigma; psiCHECK-2 from Promega. Vector plasmids: pCDH-CMV-MCS-EF1-Puro from System Biosciences; p3XFLAG-CMV™-10 from sigma; psiCHECK-2 from Promega. All primers for construction were list in Supplementary Data 4. Plasmid and siRNA transfections were performed using Lipofectamine 3,000 (Invitrogen), according to the manufacturer's protocol.
+ Open protocol
+ Expand
4

Generating Hsa-miR-3661 resistant PPP2CA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmid of encoding Hsa-miR-3661-1 and -2 was generated by inserting a PCR product from the human genomic library as a template with the primers (Forward1: 5-TGGGAATTCTGGGCGCCGGTCTCGGAGACTC-3; Reverse1: 5-TGCGG ATCCCAGCCTCAACAGCCGCCAGAAG-3; Forward2: 5-TGGGAATTCCATGTTGCAC CCTCCTCAC-3; and Reverse2: 5-TGCGGATCCAACAGCCGCCAGAAGTACAC-3) into the plasmid pCDH-CMV-MCS-EF1-Puro (SBI). The plasmid encoding Flag-human PPP2CA was generated by inserting a PCR product from a human cDNA library as the template with the primers (Forward: 5-TGAGAATTCAATGGACGAGAAGGTGTTC-3 and Reverse: 5-GTG GGATCCTTACAGGAAGTAGTCTGG-3) into the plasmid p3XFLAG-CMV (Sigma-Aldrich). Three rounds of PCR-mediated mutagenesis were done on p3XFlag-PPP2CA to generate Hsa-miR-3661 resistant PPP2CA expression plasmid with the primers (Forward: 5-CAaCTcTCgGAaTCgCAaGTgAAGAGCCTCTGCG AGAAG-3 and Reverse: 5-TCACTTGCGATTCCGAGAGTTGCTTGCACTCGTTCAGC-3), which is completely resistant to Hsa-miR-3661.
+ Open protocol
+ Expand
5

Modulating Pancreatic Cancer Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The coding sequences of human GFPT2 or YBX1 were cloned and inserted into the lentiviral vector pCDH-CMV-MCS-EF1-puro (SBI, USA) to generate GFPT2 or YBX1 expression plasmids and then lentivirus-infected pancreatic cancer cells. For shRNA, pLKO.1 puro was used to generate GFPT2 knockdown pancreatic cancer cells. The sequences of shGFPT2 were as follows: shGFPT2#1: 5′- GGTTGAACTTGCTAGTGAT -3′; shGFPT2#2: 5′- AGGTAACTTCAGTGCGTTTAT -3′. For IL-18 and YBX1 interference, the target sequences of the siRNAs were as follows: siIL-18#1: 5′- GAAUCUAAAUUAUCAGUCA -3′; siYBX1#1: 5′- GGAGGCAGCAAATGTTACA -3′. Pancreatic cancer cells were transfected with siRNAs using Lipofectamine 3000 reagent (Life Technologies, Invitrogen) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
6

Knockdown and Overexpression of KLF5 and BRCA1 Using Lentiviral Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TRC cloning vector (pLKO.1; Addgene, Cambridge, USA) was utilized to construct shRNA plasmids against KLF5 according to standard protocols
[28] (link). Targets (21 bp) against
KLF5 were 5′-CCTATAATTCCAGAGCATAAA-3′ and 5′-GCTGTAATGTATATGGCTTTA-3′. pLKO.1-shKLF5, psPAX2, and pMD2.G were cotransfected into HEK-293T cells at a ratio of 4:3:1 to generate lentiviral particles. The coding sequences of human BRCA1 were cloned and inserted into the lentiviral vector pCDH-CMV-MCS-EF1-puro (SBI, San Francisco, USA) to generate BRCA1 expression plasmids.
+ Open protocol
+ Expand
7

Generation of circRNA Expression Vectors

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the circRNA expression vector (p‐circARHGAP35), the genomic region for circARHGAP35 was amplified from HEK293T genomic DNA using PrimerSTAR Max DNA Polymerase Mix (Takara) and cloned into circular RNA expression plasmid PLCDH‐ciR (Geenseed Co, Ltd, Guangzhou, China). p‐circARHGAP35‐Flag was derived by inserting 3 × Flag sequence immediately to the upstream of stop codon of circARHGAP35. The circARHGAP35 ORF sequence or mutatant sequence (the stop codon TGA was deleted) was amplified and cloned into pCDH‐CMV‐MCS‐EF1‐Puro (SBI, Palo Alto, CA, USA) to generate p‐lin‐cORF‐Flag and p‐lin‐cORF‐Flag‐mut. p‐lin‐FL was produced by inserting a full length of ARHGAP35 ORF sequence into pCDH‐CMV‐MCS‐EF1‐Puro vector. The gRNA sequence targeting ARHGAP35 were designed and cloned into lentiGuide‐puro vector (a generous gift from Dr. Feng Zhang). pcDNA5‐FTO‐HA was a generous gift from Dr. Zefeng Wang. pTRIPZ‐circARHGAP35‐ORF was constructed by inserting the Flag‐tagged circARHGAP35 ORF sequence into the pTRIPZ vector (Open Biosystems, Huntsville, USA), a Tet‐On lentiviral expression vector. The two HNRNPL binding sites sequences were synthesized (GENEWIZ, Suzhou, China), and together with the GFP sequence were cloned into pCDH‐CMV‐MCS‐EF1‐Puro vector. The primers are all listed in Table S3, Supporting Information. All constructs were verified by sequencing.
+ Open protocol
+ Expand
8

Lentiviral-Mediated FBW7 Overexpression and CEACAM5 Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Flag-tagged coding sequence of human FBW7 was cloned into the lentiviral vector pCDH-CMV-MCS-EF1-puro (SBI, USA) to generate FBW7 expression plasmids. The siRNA of CEACAM5 targeting sequences were: 5'- GACCCUCACUCUAUUCAAU-3', 5'- CAGUACUCUUGGUUUGUCA-3' and 5'-CAAGCCCAUAACUCAGACA-3'. Cells were seeded at an approximate concentration and were cultured under standard incubation conditions for 24 hours before transfection. FBW7 expression and control vectors, and CEACAM5 and control siRNAs were transfected using Lipofectamine 2000 (Invitrogen).
+ Open protocol
+ Expand
9

Human Multiple Myeloma Cell Lines Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human multiple myeloma cell lines (HMCLs) RPMI8226, FR4, JJN3, KMS11, KMS18, MM1.R, OPM2, and U266 were maintained in RPMI1640 with 5% fetal bovine serum, 100u/ml penicillin and 100 ug/ml streptomycin. All MM cells were from Dr. Leif Bergsagel’s lab. These cells were tested for mycoplasma negative and validated by finger printing develop by Dr. Bergsagel’s lab (unpulished data). All experiments were performed on MM cells less than 20 passages after thawed from liquid nitrogen. Plasmids pCDHpuroCr expressing selection marker puromycin and pCDHgfpCr expressing a green fluorescent protein selection marker (GFP) for cloning sgRNAs were derived from pCDH-CMV-MCS-EF1-Puro and pCDH-CMV-MCS-EF1-copGFP (SBI, Mountain View, CA 94043) respectively by cloning the sgRNA expression cassette from plasmid lentiGuide-Puro (Addgene #52963).(28 (link)). Plasmid pCDHBlastCas9HA was derived from lentiCas9-blast (#52962).(28 (link)) by cloning Cas9 gene (Flag tag was replaced with HA tag) into pCDHBlast under the control of CMV promoter, which was constructed by Shi et al. (C.X. Shi; unpublished observations).
+ Open protocol
+ Expand
10

Lentiviral Vector Cloning of MEN1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The coding sequences of human
MEN1 were cloned into the lentiviral vector pCDH-CMV-MCS-EF1-puro (SBI, Palo Alto, USA) to generate pCDH-CMV-MEN1-Flag-EF1-puro. Empty vector (pCDH-CMV-MCS-EF1-puro) was used as the control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!